Company: SGBAF
Filing Date: 2025-04-29
Form Type: F-4
Source: 0001193125-25-103898
Chunk: 437

Company: SES S.A.
Filing Date: 2025-04-29
Form: F-4
Chunk 437
---
2 million for the ten months ended December 31, 2022, with no similar payments for the two months ended February 28, 2022. During the year ended December 31, 2023, the total remaining
balance of $2.8 billion associated with the 2029 Term Loans was paid in full.

Note 9—Shareholders’ Equity

(a) Share Premium Distribution

In
September 2023, our board of directors authorized and approved, subject to shareholder approval, and in December 2023, the shareholders approved, the distribution of $130.0 million out of the Company’s share premium to the shareholders of
the Company in proportion to their holdings of shares of the Company and the holders of restricted stock units pursuant to the terms of the relevant award agreements, on the relevant record date. On January 29, 2024, the Company paid $1.873 per
outstanding share to its common shareholders of record at the close of business on January 5, 2024, totaling $127.5 million. Additional payments were made and will continue to be made to holders of restricted stock units pursuant to the
terms of the relevant award agreements upon vesting of the underlying restricted stock units.

In June 2024, our board of directors
authorized and approved, subject to shareholder approval, and in September 2024, the shareholders approved, the distribution of $500.0 million out of the Company’s share premium to the shareholders of the Company in proportion to their
holdings of shares of the Company and the holders of restricted stock units pursuant to the terms of the relevant award agreements, on the relevant record date. On September 27, 2024, the Company paid $7.07 per outstanding share to its common
shareholders of record at the close of business on September 17, 2024, totaling $481.6 million. Additional payments will be made to holders of restricted stock units pursuant to the terms of the relevant award agreements upon vesting of
the underlying restricted stock units.

F-146

(b) Share Repurchase Program In September 2023, our board of directors authorized and approved, subject to shareholder approval, and in December 2023, the shareholders approved a share repurchase program authorizing for a three year period the repurchase of up to 20.0 million of the Company’s common shares, up to $200.0 million aggregate amount for which shares may be repurchased, which may be made in any manner